Project Number 3RF1AG057443-01S4 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Expanding Target Enabling Packages for AMP-AD Target Validation to identify small molecule inhibitors that block protein-protein interactions in cells Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development c. Translational Infrastructure Researcher and Organization Principal Investigator MANGRAVITE, LARA M Principal Investigator First Name PAUL Principal Investigator Last Name BRENNAN Awardee Organization SAGE BIONETWORKS Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $252,472 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
